XpressO MoCA
MoCA Cognition

Clinical
Trials

Recruiting Clinical Trials for Alzheimer's Disease
Currently recruiting Alzheimer's Disease clinical trials listed here are retrieved from clinicaltrials.gov
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Evaluating the Feasibility of elleFA App Implementation
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Deep Brain Stimulation of the Pedunculopontine Nucleus for Alzheimer's Disease
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease
TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers
Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease
Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease
A Postmarketing Study of Lecanemab in South Korean Participants With Alzheimer's Disease
MoCA XPRESSO
Available in 8 languages
English, French, Spanish, German, Italian, Japanese, Greek & Arabic
download xpresso
Download the app from both Apple App Store and Google Play Store and test your memory
Download XpressO from Apple App StoreDownload XpressO from Google Play
Login
Forgot password Register
Forgot password
Email address
Submit
Your browser window is too small

Your browser window isn't big enough to perform the XpressO MoCA test.

Please resize your browser window to make room for the test.

If you are not able to make the window bigger, you can also perform the test using our mobile app. It can be downloaded here:
Download XpressO from Apple App Store Download XpressO from Google Play

This message will disappear as soon as the browser window is large enough.
❌

Loading,
one moment
please...

Loading,
one moment
please...
Delete account

Are you sure that you want to delete your account? All test results will be lost.

Cancel
Yes
Your request has been received

Your delete request has been received. Our support team will delete your account within the next 48 hours. We thank you for placing your trust in us and using our services.

Ok